DE2844534C2 - - Google Patents
Info
- Publication number
- DE2844534C2 DE2844534C2 DE2844534A DE2844534A DE2844534C2 DE 2844534 C2 DE2844534 C2 DE 2844534C2 DE 2844534 A DE2844534 A DE 2844534A DE 2844534 A DE2844534 A DE 2844534A DE 2844534 C2 DE2844534 C2 DE 2844534C2
- Authority
- DE
- Germany
- Prior art keywords
- monoglutamate
- trimethyllysine
- treated
- vincristine
- cytostatic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU77RI649A HU179753B (en) | 1977-10-13 | 1977-10-13 | Process for producting synergetic pharmaceutical compositions of citostatic activity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE2844534A1 DE2844534A1 (de) | 1979-04-19 |
| DE2844534C2 true DE2844534C2 (US07224749-20070529-P00002.png) | 1988-03-17 |
Family
ID=11001045
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19782844534 Granted DE2844534A1 (de) | 1977-10-13 | 1978-10-12 | Arzneimittel, insbesondere mit cytostatischer wirkung |
Country Status (13)
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4659699A (en) * | 1983-08-22 | 1987-04-21 | Cetus-Ben Venue Therapeutics | Process for freeze drying cyclophosphamide |
| ATE77754T1 (de) * | 1988-02-11 | 1992-07-15 | Matrix Pharma | Zusammensetzungen zur behandlung von gehirntumoren. |
-
1977
- 1977-10-13 HU HU77RI649A patent/HU179753B/hu not_active IP Right Cessation
-
1978
- 1978-09-26 IL IL7855644A patent/IL55644A0/xx not_active IP Right Cessation
- 1978-10-04 AT AT714678A patent/AT357261B/de not_active IP Right Cessation
- 1978-10-11 AU AU40596/78A patent/AU520724B2/en not_active Expired
- 1978-10-11 FR FR7829003A patent/FR2405710A1/fr active Granted
- 1978-10-12 CA CA313,225A patent/CA1108054A/en not_active Expired
- 1978-10-12 CH CH1060978A patent/CH641672A5/de not_active IP Right Cessation
- 1978-10-12 DK DK455278A patent/DK455278A/da not_active Application Discontinuation
- 1978-10-12 DE DE19782844534 patent/DE2844534A1/de active Granted
- 1978-10-12 BE BE191065A patent/BE871197A/xx not_active IP Right Cessation
- 1978-10-12 US US05/950,579 patent/US4260595A/en not_active Expired - Lifetime
- 1978-10-12 GB GB7840315A patent/GB2006010B/en not_active Expired
- 1978-10-13 NL NL7810332A patent/NL7810332A/xx not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA1108054A (en) | 1981-09-01 |
| CH641672A5 (de) | 1984-03-15 |
| AU4059678A (en) | 1980-04-17 |
| BE871197A (fr) | 1979-04-12 |
| FR2405710B1 (US07224749-20070529-P00002.png) | 1981-07-31 |
| AU520724B2 (en) | 1982-02-25 |
| AT357261B (de) | 1980-06-25 |
| US4260595A (en) | 1981-04-07 |
| DE2844534A1 (de) | 1979-04-19 |
| NL7810332A (nl) | 1979-04-18 |
| HU179753B (en) | 1982-12-28 |
| DK455278A (da) | 1979-04-14 |
| ATA714678A (de) | 1979-11-15 |
| GB2006010A (en) | 1979-05-02 |
| IL55644A0 (en) | 1978-12-17 |
| FR2405710A1 (fr) | 1979-05-11 |
| GB2006010B (en) | 1982-06-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69923322T2 (de) | Verwendung von propionyl-l-carnitin und acetyl-l-carnitin zur herstellung von arzneimittel mit antikrebs wirkung | |
| DE69822665T2 (de) | Verwendung von 9-desoxy-2',9-alpha-methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylen)-13,14-dihydroprostaglandin-f1 zur behandlung von peripheren vaskulären erkrankungen | |
| EP0242328A2 (de) | Arzneimittel zur Behandlung von Entzündungen im Auge | |
| DE3786893T2 (de) | Piperidinderivat zur Schmerzbehandlung. | |
| DE2523998A1 (de) | Pharmazeutische zubereitung fuer die behandlung der schizophrenie | |
| EP0185210B1 (de) | Verwendung von Dipeptidderivaten für die Herstellung von Arzneimitteln zur Behandlung von an amyotropher Lateralsklerose Erkrankten | |
| CH660969A5 (de) | Verwendung von thiadiazinverbindungen. | |
| DE3390116C2 (de) | Verbesserte, Koffein enthaltende, analgetische und antiinflammatorische Mittel | |
| DE69605531T2 (de) | Carnitinderivat als Arzneimittel zur Behandlung von Arteriosklerose obliterans | |
| DE3536560A1 (de) | Augentropfen enthaltend bromokryptin | |
| DE2844534C2 (US07224749-20070529-P00002.png) | ||
| DE69937574T2 (de) | Verwendung des pharmazeutischen präparates "histochrome" zur behandlung des akuten herzinfarkts und ischämischer herzerkrankungen | |
| EP1001756B1 (de) | Synergistisch wirkende zusammensetzungen zur selektiven bekämpfung von tumorgewebe | |
| DE69821024T2 (de) | Parenterale zubereitungen enthaltend 10-hydroxy-10,11-tetrahydrocarbamazepine, wasser und glukose | |
| DE60216292T2 (de) | Calciumtrifluoracetat mit zytotoxischer wirkung | |
| DE69115102T2 (de) | Stabilisator für eine 4-ethyl-2-hydroxyimino-5-nitro-3-hexenamide enthaltende Zusammensetzung und Stabilisierungsverfahren. | |
| DE1900772C3 (de) | Salz aus N,N-Dimethylbiguanid und p-Chlorphenoxyessigsäure sowie dieses enthaltende Arzneimittel | |
| DE2528460A1 (de) | Verwendung von l-carboxamido-2- cyan-aziridin als immunstimulans | |
| DE60122384T2 (de) | Verfahren zur herstellung einer beständige pharmazeutische form von paclitaxel | |
| DE3011274A1 (de) | Synergistische strahlenschuetzende pharmazeutische praeparate sowie deren herstellung | |
| DD141995A5 (de) | Verfahren zur herstellung detoxifizierter zubereitungen von cytostatika | |
| DE69426295T2 (de) | Organkonservierungsmittel | |
| DE69528068T2 (de) | Conagenine zur prävention und behandlung von diarrhöe | |
| DE2625220A1 (de) | Arzneipraeparate mit einem gehalt an 1,3-dithiaverbindungen | |
| DE60012183T2 (de) | Verwendung einer makrolid-verbindung zur herstellung eines medikaments zur behandlung von gehirnschäden aufgrund von ischämie oder blutungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8110 | Request for examination paragraph 44 | ||
| D2 | Grant after examination | ||
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |